- Home
- GANX vs AGMH Comparison
GANX vs AGMH Comparison
Compare GANX & AGMH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GANX | AGMH |
|---|---|---|
| Founded | 2017 | 2015 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 88.6M | 5.0M |
| IPO Year | 2021 | 2017 |
Fundamental Metrics
Financial Performance| Metric | GANX | AGMH |
|---|---|---|
| Price | $1.78 | $0.79 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $7.50 | N/A |
| AVG Volume (30 Days) | 312.3K | ★ 549.9K |
| Earning Date | 05-13-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 31.46 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $55,180.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $0.07 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.53 | $0.70 |
| 52 Week High | $4.34 | $18.10 |
Technical Indicators
Market Signals| Indicator | GANX | AGMH |
|---|---|---|
| Relative Strength Index (RSI) | 41.76 | 29.48 |
| Support Level | $1.71 | N/A |
| Resistance Level | $1.85 | $1.38 |
| Average True Range (ATR) | 0.07 | 0.11 |
| MACD | -0.01 | -0.02 |
| Stochastic Oscillator | 14.29 | 0.21 |
Price Performance
Historical ComparisonAbout GANX Gain Therapeutics Inc.
Gain Therapeutics Inc is a clinical-stage biotechnology company developing novel small-molecule therapeutics to treat diseases across several therapeutic areas, including central nervous system (CNS) disorders, lysosomal storage disorders (LSDs), metabolic disorders, and other diseases that can be targeted through protein degradation, such as oncology. The Company's clinical stage product candidate, GT-02287, is being developed for the treatment of Parkinson's disease with and without GBA1 mutations. The Company generated an extensive preclinical data package providing evidence of the mechanism of action.
About AGMH AGM Group Holdings Inc.
AGM Group Holdings Inc is a technology company engaged in technology hardware research and development, manufacturing, assembly, and sales. Its core business segments include research and development of blockchain-oriented ASIC chips, production of high-end crypto miners for Bitcoin and other cryptocurrencies, and Fintech software services. The Company mainly derives revenue from the sales of cryptocurrency mining machines and standardized computing equipment.